Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$300,000.00
Nov 1, 2016
Monies allocated over more than one fiscal year;Repayable Contribution
$92,358.00
Nov 1, 2016
Monies allocated over more than one fiscal year;Non-repayable contribution
$300,000.00
Nov 1, 2016
Monies allocated over more than one fiscal year;Non-repayable contribution
$500,000.00
Nov 1, 2016
Canada Research Chairs Tier 2
$500,000.00
Nov 1, 2016
Canada Research Chair - Tier 2
$300,000.00
Nov 1, 2016
Development, Implementation and Evaluation of Interventions for Youth Injured by Violence
$199,812.00
Nov 1, 2016
Child developmental health, maternal psychosocial distress, and health system costs at 18 months corrected age: Effectiveness of a cluster randomized controlled trial of Family Integrated Care in Level II NICUs
$250,000.00
Nov 1, 2016
The role of envelope glycosylation on HIV-1 transmission efficiency
$250,000.00
Nov 1, 2016
The role of CD71+ cells in HIV pathogenesis: Reactivation of latent HIV by CD71+ cells and Galectin-9
$109,216.00
Nov 1, 2016
Immuno-modulatory HIV-1 nanoparticles as a novel vaccine platform